HIGHLIGHTS
- who: Andrei C. Sposito from the Division of Cardiology, State University of Campinas (Unicamp), Campinas, Sao Paulo, u2011971, Brazil have published the paper: Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial, in the Journal: (JOURNAL) of March/20,/2020
- what: The study showed that FMD measured after an arterial challenge with a 15-min period of ischemia and reperfusion improved after evolocumab therapy. This study also adds to the current evidence that PCSK9i therapy increases the duration of brachial artery dilation after cuff deflation, evaluated both by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.